KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to $17.6 million.

  • Emergent BioSolutions' Change in Inventory fell 222.22% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 23838.38%. This contributed to the annual value of $24.5 million for FY2024, which is 418333.33% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Change in Inventory is $17.6 million, which was down 222.22% from $24.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Change in Inventory registered a high of $99.9 million during Q1 2021, and its lowest value of -$45.7 million during Q4 2022.
  • For the 5-year period, Emergent BioSolutions' Change in Inventory averaged around $10.1 million, with its median value being $8.6 million (2021).
  • As far as peak fluctuations go, Emergent BioSolutions' Change in Inventory plummeted by 63139.53% in 2022, and later soared by 1790000.0% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Change in Inventory (Quarter) stood at $8.6 million in 2021, then plummeted by 631.4% to -$45.7 million in 2022, then skyrocketed by 43.98% to -$25.6 million in 2023, then skyrocketed by 57.03% to -$11.0 million in 2024, then skyrocketed by 260.0% to $17.6 million in 2025.
  • Its Change in Inventory was $17.6 million in Q3 2025, compared to $24.7 million in Q2 2025 and $2.2 million in Q1 2025.